BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25300787)

  • 1. A search for functional histamine H4 receptors in the human, guinea pig and mouse brain.
    Feliszek M; Speckmann V; Schacht D; von Lehe M; Stark H; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):11-7. PubMed ID: 25300787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
    Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptors.
    Petri D; Schlicker E
    Neuropharmacology; 2016 Jul; 106():129-34. PubMed ID: 26211976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.
    Nickel T; Bauer U; Schlicker E; Kathmann M; Göthert M; Sasse A; Stark H; Schunack W
    Br J Pharmacol; 2001 Apr; 132(8):1665-72. PubMed ID: 11309237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430.
    Lim HD; Adami M; Guaita E; Werfel T; Smits RA; de Esch IJ; Bakker RA; Gutzmer R; Coruzzi G; Leurs R
    Br J Pharmacol; 2009 May; 157(1):34-43. PubMed ID: 19413569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation.
    Chan NY; Robador PA; Levi R
    J Pharmacol Exp Ther; 2012 Dec; 343(3):568-77. PubMed ID: 22923736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
    Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
    Clark EA; Hill SJ
    Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
    Schlicker E; Marr I
    Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
    Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
    Schlicker E; Kathmann M; Bitschnau H; Marr I; Reidemeister S; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):482-8. PubMed ID: 8740140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
    Fink K; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):113-7. PubMed ID: 8170496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of histamine receptors in SAPK/JNK phosphorylation.
    Dandekar RD; Khan MM
    Int Immunopharmacol; 2012 Jun; 13(2):190-6. PubMed ID: 22487127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
    Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz JC; Arrang JM
    Br J Pharmacol; 2002 Jan; 135(2):383-92. PubMed ID: 11815373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors.
    Breunig E; Michel K; Zeller F; Seidl S; Weyhern CW; Schemann M
    J Physiol; 2007 Sep; 583(Pt 2):731-42. PubMed ID: 17627982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
    Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
    J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.